Anti-NIM1K monoclonal antibody

Pre-made anti-NIM1K monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to NIM1K/NIM1K products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1266-Ab-1/ GM-Tg-hg-IP1266-Ab-2Anti-Human NIM1K monoclonal antibodyHuman
GM-Tg-rg-IP1266-Ab-1/ GM-Tg-rg-IP1266-Ab-2Anti-Rat NIM1K monoclonal antibodyRat
GM-Tg-mg-IP1266-Ab-1/ GM-Tg-mg-IP1266-Ab-2Anti-Mouse NIM1K monoclonal antibodyMouse
GM-Tg-cynog-IP1266-Ab-1/ GM-Tg-cynog-IP1266-Ab-2Anti-Cynomolgus/ Rhesus macaque NIM1K monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1266-Ab-1/ GM-Tg-felg-IP1266-Ab-2Anti-Feline NIM1K monoclonal antibodyFeline
GM-Tg-cang-IP1266-Ab-1/ GM-Tg-cang-IP1266-Ab-2Anti-Canine NIM1K monoclonal antibodyCanine
GM-Tg-bovg-IP1266-Ab-1/ GM-Tg-bovg-IP1266-Ab-2Anti-Bovine NIM1K monoclonal antibodyBovine
GM-Tg-equg-IP1266-Ab-1/ GM-Tg-equg-IP1266-Ab-2Anti-Equine NIM1K monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1266-Ab-1/ GM-Tg-hg-IP1266-Ab-2; GM-Tg-rg-IP1266-Ab-1/ GM-Tg-rg-IP1266-Ab-2;
GM-Tg-mg-IP1266-Ab-1/ GM-Tg-mg-IP1266-Ab-2; GM-Tg-cynog-IP1266-Ab-1/ GM-Tg-cynog-IP1266-Ab-2;
GM-Tg-felg-IP1266-Ab-1/ GM-Tg-felg-IP1266-Ab-2; GM-Tg-cang-IP1266-Ab-1/ GM-Tg-cang-IP1266-Ab-2;
GM-Tg-bovg-IP1266-Ab-1/ GM-Tg-bovg-IP1266-Ab-2; GM-Tg-equg-IP1266-Ab-1/ GM-Tg-equg-IP1266-Ab-2
Products NameAnti-NIM1K monoclonal antibody
Formatmab
Target NameNIM1K
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-NIM1K monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1266-Ag-1Recombinant multi-species NIM1/ NIM1K protein
    ORF Viral VectorvGMLP001872human NIM1K Lentivirus particle
    ORF Viral VectorpGMLP001872human NIM1K Lentivirus plasmid
    ORF Viral VectorpGMLPm004844mouse Nim1k Lentivirus plasmid
    ORF Viral VectorvGMLPm004844mouse Nim1k Lentivirus particle


    Target information

    Target IDGM-IP1266
    Target NameNIM1K
    Gene ID167359,245269,310376,699870,489218,101092240,530210,100052865
    Gene Symbol and SynonymsE130304F04Rik,NIM1,NIM1K,RGD1308116
    Uniprot AccessionQ8IY84
    Uniprot Entry NameNIM1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000177453
    Target ClassificationKinase

    The target: NIM1K, gene name: NIM1K, also named as NIM1. Enables ATP binding activity; magnesium ion binding activity; and protein serine/threonine kinase activity. Involved in protein phosphorylation. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.